1. Home
  2. LFMD vs CGEM Comparison

LFMD vs CGEM Comparison

Compare LFMD & CGEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LFMD
  • CGEM
  • Stock Information
  • Founded
  • LFMD 1994
  • CGEM 2016
  • Country
  • LFMD United States
  • CGEM United States
  • Employees
  • LFMD N/A
  • CGEM N/A
  • Industry
  • LFMD Medical/Nursing Services
  • CGEM Biotechnology: Pharmaceutical Preparations
  • Sector
  • LFMD Health Care
  • CGEM Health Care
  • Exchange
  • LFMD Nasdaq
  • CGEM Nasdaq
  • Market Cap
  • LFMD 552.6M
  • CGEM 530.0M
  • IPO Year
  • LFMD N/A
  • CGEM 2021
  • Fundamental
  • Price
  • LFMD $12.93
  • CGEM $7.76
  • Analyst Decision
  • LFMD Strong Buy
  • CGEM Strong Buy
  • Analyst Count
  • LFMD 5
  • CGEM 5
  • Target Price
  • LFMD $11.00
  • CGEM $30.00
  • AVG Volume (30 Days)
  • LFMD 2.0M
  • CGEM 364.4K
  • Earning Date
  • LFMD 08-06-2025
  • CGEM 08-07-2025
  • Dividend Yield
  • LFMD N/A
  • CGEM N/A
  • EPS Growth
  • LFMD N/A
  • CGEM N/A
  • EPS
  • LFMD N/A
  • CGEM N/A
  • Revenue
  • LFMD $234,007,330.00
  • CGEM N/A
  • Revenue This Year
  • LFMD $29.80
  • CGEM N/A
  • Revenue Next Year
  • LFMD $18.03
  • CGEM N/A
  • P/E Ratio
  • LFMD N/A
  • CGEM N/A
  • Revenue Growth
  • LFMD 43.07
  • CGEM N/A
  • 52 Week Low
  • LFMD $3.99
  • CGEM $6.85
  • 52 Week High
  • LFMD $15.84
  • CGEM $21.01
  • Technical
  • Relative Strength Index (RSI)
  • LFMD 53.19
  • CGEM 43.41
  • Support Level
  • LFMD $12.46
  • CGEM $7.26
  • Resistance Level
  • LFMD $14.43
  • CGEM $8.00
  • Average True Range (ATR)
  • LFMD 0.95
  • CGEM 0.44
  • MACD
  • LFMD -0.25
  • CGEM -0.09
  • Stochastic Oscillator
  • LFMD 22.19
  • CGEM 27.98

About LFMD LifeMD Inc.

LifeMD Inc is a direct-to-patient telehealth company that provides a smarter, cost-effective, and more convenient way of accessing comprehensive, virtual healthcare. Its telehealth platform seamlessly integrates a clinician-centric electronic medical record (EMR) system, proprietary algorithms for case-load balancing and scheduling, customer relationship management functionality, remote and in-home lab testing, and digital prescription capabilities, patient-provider audio/video interfacing, cloud pharmacy fulfillment, and more. In addition to telehealth offerings, the company sells nutritional supplements and other over-the-counter products. The company has two operating segments: Telehealth and WorkSimpli. The company generates the majority of its revenue from the Telehealth segment.

About CGEM Cullinan Oncology Inc.

Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, creates differentiated ideas, identifies the appropriate targets, and selects the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications. It has one reporting and one operating segment, which is the business of developing immunology and oncology therapies.

Share on Social Networks: